Motto Nuga-Cel! - Need help replacing some CGs with the ones from the other version GBAtemp.net - 27 Apr 2024 Motto Nuga-Cel! - Need help replacing some CGs with the ones from the other version ... More
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel FiercePharma - 23 Apr 2024 FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel ... More
FDA pushes back decision date on pz-cel treatment for RDEB Epidermolysis Bullosa News - 26 Apr 2024 FDA pushes back decision date on pz-cel treatment for RDEB ... More
Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM AJMC.com Managed Markets Network - 24 Apr 2024 Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM ... More
Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma www.oncnursingnews.com/ - 26 Apr 2024 Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma ... More
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy OncLive - 22 Apr 2024 European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ... More
CEL-SCI Appoints Mario Gobbo to Its Board of Directors Business Wire - 23 Apr 2024 CEL-SCI Appoints Mario Gobbo to Its Board of Directors ... More
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment Contemporary Pediatrics - 23 Apr 2024 CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment ... More
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD MD Magazine - 06 Mar 2024 The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD ... More
Call of Duty's upcoming Cel-Shaded skin opens new crossover possibilities in Warzone and MW3 Sportskeeda - 25 Apr 2024 Call of Duty's upcoming Cel-Shaded skin opens new crossover possibilities in Warzone and MW3 ... More
Afami-cel provides a novel treatment option for rare sarcoma subtypes Nature.com - 18 Apr 2024 Afami-cel provides a novel treatment option for rare sarcoma subtypes ... More
CEL-SCI Corporation Issues Letter to Shareholders Yahoo Finance - 06 Mar 2024 CEL-SCI Corporation Issues Letter to Shareholders ... More
FDA Approves Ide-Cel in Previously Treated Multiple Myeloma Cancer Network - 05 Apr 2024 FDA Approves Ide-Cel in Previously Treated Multiple Myeloma ... More
CRCHD Announces the Establishment of Cancer Equity Leaders to Contribute to Health Equity Efforts National Cancer Institute (.gov) - 08 Apr 2024 CRCHD Announces the Establishment of Cancer Equity Leaders to Contribute to Health Equity Efforts ... More
FDA Approves Ide-Cel for Triple-Class Exposed R/R Multiple Myeloma OncLive - 05 Apr 2024 FDA Approves Ide-Cel for Triple-Class Exposed R/R Multiple Myeloma ... More
Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma OncLive - 22 Apr 2024 Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma ... More
FDA Grants Priority Review to Expand Liso-Cel Indications in R/R Follicular Lymphoma and MCL OncLive - 30 Jan 2024 FDA Grants Priority Review to Expand Liso-Cel Indications in R/R Follicular Lymphoma and MCL ... More
FDA Approval Sought for Obe-Cel in Relapsed/Refractory B-ALL OncLive - 27 Nov 2023 FDA Approval Sought for Obe-Cel in Relapsed/Refractory B-ALL ... More
FELIX Pooled Analysis Findings Potentiate Further Obe-Cel Development in B-ALL OncLive - 12 Feb 2024 FELIX Pooled Analysis Findings Potentiate Further Obe-Cel Development in B-ALL ... More